| Literature DB >> 9667602 |
R B Wilson1, D R Lynch, K H Fischbeck.
Abstract
Friedreich's ataxia (FRDA) is caused by point mutations or trinucleotide repeat expansions in both alleles of the gene encoding frataxin. Studies of frataxin homologues in lower eukaryotes suggest that mitochondrial iron accumulation may underlie the pathophysiology of FRDA. To evaluate the possible role of iron-chelation therapy for FRDA, we measured serum iron and ferritin concentrations in 10 FRDA patients. The measurements were within normal limits, suggesting that iron-chelation therapy for FRDA may be problematic.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9667602 DOI: 10.1002/ana.410440121
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422